Hypophosphatasia: Validation and expansion of the clinical nosology for children from 25years experience with 173 pediatric patients

Bone

Volumn 75, Issue , 2015, Pages 229-239

  Whyte, Michael P ^a,b   Zhang, Fan ^a   Wenkert, Deborah ^a,e   McAlister, William H ^c   Mack, Karen E ^a   Benigno, Marci C ^a   Coburn, Stephen P ^d   Wagy, Susan ^a   Griffin, Donna M ^a   Ericson, Karen L ^d   Mumm, Steven ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST LOUIS CHILDREN S HOSPITAL   (United States)

^d INDIANA UNIVERSITY PURDUE UNIVERSITY FORT WAYNE   (United States)

^e AMGEN INC   (United States)

Author keywords

Alkaline phosphatase; DXA; Inborn error of metabolism; Inorganic pyrophosphate; Mineralization; Rickets

Indexed keywords

AGE; AMERICAN; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BODY HEIGHT; BODY SIZE; BODY WEIGHT; BONE DENSITY; BONE DISEASE; CHILD; CLINICAL FEATURE; COMPLICATION; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENE DOSAGE; GRIP STRENGTH; HIP; HUMAN; HYPOPHOSPHATASIA; MAJOR CLINICAL STUDY; MALE; MUTATION; PERIODONTAL DISEASE; PROGNOSIS; SPINE; STRENGTH; VALIDATION PROCESS; ADOLESCENT; GENETICS; INFANT; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ALKALINE PHOSPHATASE; ALPL PROTEIN, HUMAN;

ADOLESCENT; ALKALINE PHOSPHATASE; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPOPHOSPHATASIA; INFANT; MALE; MUTATION; YOUNG ADULT;

EID: 84925378783     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2015.02.022     Document Type: Article

References (54)

1. Whyte M.P. Hypophosphatasia. Genetics of bone biology and skeletal disease 2013, 337-360. Elsevier (Academic Press), San Diego, CA. R.V. Thakker, M.P. Whyte, J. Eisman, T. Igarashi (Eds.).
2. Whyte M.P. Hypophosphatasia: nature's window on alkaline phosphatase function in humans. Principles of bone biology 2008, 1573-1598. Academic Press, San Diego. 3rd ed. J.P. Bilezikian, L.G. Raisz, T.J. Martin (Eds.).
3. Russell R.G. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet 1965, 10:461-464.
4. Russell R.G., Bisaz S., Donath A., Morgan D.B., Fleisch H. Inorganic pyrophosphate in plasma in normal persons and in patients with hypophosphatasia, osteogenesis imperfecta, and other disorders of bone. J Clin Invest 1971, 50:961-969.
5. Fleisch H., Russell R.G., Straumann F. Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 1966, 212:901-903.
6. Caswell A.M., Whyte M.P., Russell R.G. Hypophosphatasia and the extracellular metabolism of inorganic pyrophosphate: clinical and laboratory aspect. Crit Rev Clin Lab Sci 1991, 28:175-232.
7. Whyte M.P., Mahuren J.D., Vrabel L.A., Coburn S.P. Markedly increased circulating pyridoxal-5'-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest 1985, 76:752-756.
8. Coburn S.P., Whyte M.P. Role of phosphatases in the regulation of vitamin B-6 metabolism in hypophosphatasia and other disorders. Clinical and physiological applications of vitamin B-6 1988, 65-93. Alan R. Liss, New York. J.E. Leklem, R.D. Reynolds (Eds.).
9. Guañabens N., Mumm S., Möller I., González-Roca E., Peris P., Demertzis J.L., et al. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res 2014, 29:929-934.
10. Baumgartner-Sigl S., Haberlandt E., Mumm S., Scholl-Bürgi S., Sergi C., Ryan L., et al. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone 2007, 40:1655-1661.
11. Whyte M.P., Greenberg C.R., Salman N.J., Bober M.B., McAlister W.H., Van Sickle B., et al. Enzyme replacement therapy in life-threatening hypophosphatasia. N Engl J Med 2012, 366:904-913.
12. Rathbun Hypophosphatasia: a new developmental anomaly. Am J Dis Child 1948, 75:822-831.
13. Leung E.C.W., Mhanni A.A., Reed M., Whyte M.P., Landy H., Greenberg C.R. Outcome of perinatal hypophosphatasia in Manitoba Mennonites: a retrospective cohort analysis. J Inherit Metab Dis Rep 2013, 11:73-78.
14. Whyte M.P., Teitelbaum S.L., Murphy W.A., Bergfeld M.A., Avioli L.V. Adult hypophosphatasia. Clinical, laboratory, and genetic investigation of a large kindred with review of the literature. Medicine (Baltimore) 1979, 58:329-347.
15. Whyte M.P., Murphy W.A., Fallon M.D. Adult hypophosphatasia with chondrocalcinosis and arthropathy. Variable penetrance of hypophosphatasemia in a large Oklahoma kindred. Am J Med 1982, 72:631-641.
16. Weiss M.J., Cole D.E., Ray K., Whyte M.P., Lafferty M.A., Mulivor R.A., et al. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci U S A 1988, 85:7666-7669.
17. Henthorn P.S., Raducha M., Fedde K.N., Lafferty M.A., Whyte M.P. Different missense mutations at the tissue-nonspecific alkaline phosphatase gene locus in autosomal recessively inherited forms of mild and severe hypophosphatasia. Proc Natl Acad Sci U S A 1992, 89:9924-9928.
18. Mornet E. Tissue nonspecific alkaline phosphatase gene mutations database [internet] 2004, University of Versailles-Saint Quentin, Yvelines, France, [cited 2014 July 4. Available from: http://www.sesep.uvsq.fr/03_hypo_mutations.php/].
19. Silvent J., Gasse B., Mornet E., Sire J.-Y. Molecular evolution of the tissue-nonspecific alkaline phosphatase allows prediction and validation of missense mutations responsible for hypophosphatasia. J Biol Chem 2014, 289:24168-24179.
20. Mornet E. Genetics of hypophosphatasia. Clinical rev Bone and Mineral Metabolism 2013, 11:71-77.
21. Fraser D. Hypophosphatasia. Am J Med 1957, 22:730-746.
22. Currarino G., Neuhauser E.B.D., Reyersbach G.C., Sobel E.H. Hypophosphatasia. Am J Roentgenol Radium Ther Nucl Med 1957, 78:392-419.
23. Wenkert D., McAlister W.H., Coburn S.P., Zerega J.A., Ryan L.M., Ericson K.L., et al. Hypophosphatasia: non-lethal disease despite skeletal presentation in utero (17 new cases and literature review). J Bone Miner Res 2011, 26:2389-2398.
24. Weinstein R.S., Whyte M.P. Fifty-year follow-up of hypophosphatasia. Arch Intern Med 1981, 141:1720-1721.
25. Khandwala H.M., Mumm S., Whyte M.P. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood. Endocr Pract 2006, 12:676-681.
26. Sutton R.A.L., Mumm S., Coburn S.P., Ericson K.L., Whyte M.P. "Atypical femoral fractures" during bisphosphonate exposure in adult hypophosphatasia. J Bone Miner Res 2012, 27:987-994.
27. Whyte M.P., Mumm S., Deal C. Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 2007, 92:1203-1208.
28. Fallon M.D., Weinstein R.S., Goldfischer S., Brown D.S., Whyte M.P. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore) 1984, 63:12-24.
29. Sobel E.H., Clark L.C., Fox R.P., Robinow M. Rickets, deficiency of "alkaline" phosphatase activity and premature loss of teeth in childhood. Pediatrics 1953, 11:309-321.
30. Whyte M.P., Essmyer K., Geimer M., Mumm S. Homozygosity for TNSALP mutation 1348C>T (Arg 433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. J Pediatr 2006, 148:753-758.
31. Lundgren T., Westphal O., Bolme P., Modeer T., Noren J.G. Retrospective study of children with hypophosphatasia with reference to dental changes. Scand J Dent Res 1991, 99:357-364.
32. Seshia S.S., Derbyshire G., Haworth J.C., Hoogstraten J. Myopathy with hypophosphatasia. Arch Dis Child 1990, 65:130-131.
33. Whyte M.P., Valdes R., Ryan L.M., McAlister W.H. Infantile hypophosphatasia: enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone disease. J Pediatr 1982, 101:379-386.
34. Whyte M.P., McAlister W.H., Patton L.S., Magill H.L., Fallon M.D., Lorentz W.B., et al. Enzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: results in three additional patients. J Pediatr 1984, 105:926-933.
35. Whyte M.P., Kurtzburg J., McAlister W.H., Podgornik M.N., Mumm S.R., Coburn S.P., et al. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 2003, 18:624-636.
36. Cahill R.A., Wenkert D., Perlman S.A., Steele A., Coburn S.P., McAlister W.H., et al. Infantile hypophosphatasia: trial of transplantation therapy using bone fragments and cultured osteoblasts. J Clin Endocrinol Metab 2007, 92:2923-2930.
37. Ish-shalom S., Budden F., Fraser D., Harrison J., Josse R.G., Kirsh J., et al. A follow-up of hypophosphatasia from infancy to adulthood (abstract). Presented at the annual meeting of the Pediatric Working Group, American Society for Bone and Mineral Research 1986.
38. Whyte M.P., Mahuren J.D., Fedde K.N., Cole F.S., McCabe E.R., Coburn S.P. Perinatal hypophosphatasia: tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5'-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest 1988, 81:1234-1239.
39. ClinicalTrials.gov; A Service of the U.S. National Institutes of Health http://clinicaltrials.gov/ct2/results?term=Hypophosphatasia.
40. Whyte M.P. Hypophosphatasia. The metabolic and molecular bases of inherited disease 2001, 5313-5329. McGraw-Hill Book Company, New York. 8th ed. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle, B. Childs, B. Vogelstein (Eds.).
41. Whyte M.P., Kempa L.G., McAlister W.H., Zhang F., Mumm S., Wenkert D. Elevated serum lactate dehydrogenase isoenzymes and aspartate transaminase distinguish Albers-Schonberg Disease (Chloride Channel 7 Deficiency Osteopetrosis) among the sclerosing bone disorders. J Bone Miner Res 2010, 25:2515-2526.
42. Lee-Valkov P.M., Aaron D.H., Eladoumikdachi F., Thornby J., Netscher D.T. Measuring normal hand dexterity values in normal 3-, 4-, and 5-year-old children and their relationship with grip and pinch strength. J Hand Ther 2003, 16:22-28.
43. Mathiowetz V., Wiemer D.M., Federman S.M. Grip and pinch strength: norms for 6- to 19-year-olds. Am J Occup Ther 1986, 40:705-711.
44. Bouyoucef S.E., Cullum I.D., Ell P.J. Cross-calibration of a fan-beam X-ray densitometer with a pencil-beam system. Br J Radiol 1996, 69:522-531.
45. Kelly T.L., Specker B.L., Binkley T., et al. Pediatric BMD reference database for U.S. white children. Bone 2005, 36(Suppl. 1):30.
46. Zhang F., Whyte M.P., Wenkert D. Dual-energy X-ray absorptiometry interpretation: a simple equation for height correction in preteenage children. J Clin Densitom 2012, 15:267-274.
47. Mumm S., Jones J., Finnegan P., Henthorn P., Podgornik M.N., Whyte M.P. Denaturing gradient gel electrophoresis analysis of the tissue non-specific alkaline phosphatase isoenzyme gene in hypophosphatasia. Mol Genet Metab 2002, 75:143-153.
48. Annual Estimates of the Resident Population for the United States, Annual Estimates of the Resident Population for the United States, Regions States [internet] [cited 2014 June 1. Available from:. http://www.census.gov/popest/data/historical/2000s/vintage_2008/index.html.].
49. 317 β Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian Mennonites. Genomics 1993, 17:215-217.
50. Chumlea W.C., Schubert C.M., Roche A.F., Kulin H.E., Lee P.A., Himes J.H., et al. Age at menarche and racial comparison in US girls. Pediatrics 2003, 111:110-113.
51. Watanabe A., Satoh S., Fujita A., Naing B.T., Orimo H., Shimada T. Perinatal hypophosphatasia caused by uniparental isodisomy. Bone 2014, 60:93-97.
52. Mumm S., Wenkert D., Zhang X., Geimer M., Zerega J., Whyte M.P. Hypophosphatasia: the c.1133A>T, p.D378V transversion is the most common American TNSALP mutation. J Bone Miner Res 2006, (Suppl. 1). [Abstract], [http://www.abstractsonline.com/viewer/viewAbstractPrintFriendly.asp?CKey={B11501E4-A3C4-43B3-9256-8570395E1277}&SKey={ACBF01A6-69A9-4204-8600-ADF1DDE684A3}&MKey={FC197A55-D8DD-4F3D-9994-290B64584CCB}&AKey={D0C01D4F-E23B-45E2-ACD4-0AF8AC866B8B}].
53. Wenkert D., McAlister W.M., Mumm S., Whyte M.P. c.1250A>G, p.N417S is a common American TNSALP mutation involved in all clinical forms of hypophosphatasia (HPP), including pseudo-HPP. J Bone Miner Res 2008, (Suppl. 1). [Abstract], [http://www.abstractsonline.com/viewer/viewAbstractPrintFriendly.asp?CKey={54E5FA0D-4A7A-43FB-849C-FDCDD1829EFB}&SKey={3C52A7B3-7E9C-4FE5-9C40-A94007242039}&MKey={DCB70C83-5B38-431A-B0E1-9221D66718D0}&AKey={D0C01D4F-E23B-45E2-ACD4-0AF8AC866B8B}].
54. Grimberg A., Feemster K.A., Pati S., Ramos M., Grundmeier R., Cucchiara A.J., et al. Medically underserved girls receive less evaluation for short stature. Pediatrics 2011, 127:696-702.